Stay updated on Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    No significant changes detected in core study information (eligibility criteria, locations, primary/secondary outcomes, or overall study description). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T00:58:10.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    42 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.
    Difference
    3%
    Check dated 2025-10-05T09:01:03.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T03:04:15.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Updated revision from v3.0.1 to v3.0.2; removed the Back to Top element.
    Difference
    0.2%
    Check dated 2025-09-13T16:54:49.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-06T14:27:23.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a new facility name and specific locations in Washington D.C. and St. Louis, while also removing various terms related to genetic diseases and pharmacological classifications.
    Difference
    2%
    Check dated 2025-08-30T11:15:56.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial page.